1. Regeneron starting late stage trials of coronavirus drug cocktail — Bristol-Myers pays Dragonfly Therapeutics $55M to bring NK cells to neuro diseases — JNJ in $480M-plus deal with Emergent for coronavirus vaccine supply — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice


Discussion in 'Solta Medical' started by Anonymous, Feb 5, 2015 at 7:00 PM.

  1. Anonymous

    Anonymous Guest

    What is the base pay and commission for the capital and disposable reps at this company? Is it worth looking into coming from diagnostics trying to break into device?
  2. Anonymous

    Anonymous Guest

    Base $80K
    Commission: variable, based on device and portfolio

    Par should gross $160K....upside to $240K+